Abstract
It is generally believed that multiple Ca2+ stores are present in cells, a notion that has now been made substantive by the discovery of multiple Ca2+ mobilizing messengers. Cyclic ADP-ribose (cADPR) and nicotinic acid dinucleotide phosphate (NAADP) are two such messengers that are derived from NAD and NADP, respectively. A wide variety of cells, from plants to mammals, including human, have been shown to be responsive to these two novel Ca2+ messengers. Not only are their structures and mechanisms of action different, their targeted Ca2+ stores are also distinct and separable. This article explores the implications of the multiplicity of Ca2+ stores in cellular signaling. Special emphasis will be put on the recent progress in the understanding of the physiological functions of NAADP.
Keywords: cyclic adp-ribose (cadpr), naadp, adp-ribosyl cyclase, cd38, mobilization
Current Molecular Medicine
Title: Multiplicity of Ca2+ Messengers and Ca2+ Stores: A Perspective from Cyclic ADP-Ribose and NAADP
Volume: 4 Issue: 3
Author(s): Hon Cheung Lee
Affiliation:
Keywords: cyclic adp-ribose (cadpr), naadp, adp-ribosyl cyclase, cd38, mobilization
Abstract: It is generally believed that multiple Ca2+ stores are present in cells, a notion that has now been made substantive by the discovery of multiple Ca2+ mobilizing messengers. Cyclic ADP-ribose (cADPR) and nicotinic acid dinucleotide phosphate (NAADP) are two such messengers that are derived from NAD and NADP, respectively. A wide variety of cells, from plants to mammals, including human, have been shown to be responsive to these two novel Ca2+ messengers. Not only are their structures and mechanisms of action different, their targeted Ca2+ stores are also distinct and separable. This article explores the implications of the multiplicity of Ca2+ stores in cellular signaling. Special emphasis will be put on the recent progress in the understanding of the physiological functions of NAADP.
Export Options
About this article
Cite this article as:
Lee Cheung Hon, Multiplicity of Ca2+ Messengers and Ca2+ Stores: A Perspective from Cyclic ADP-Ribose and NAADP, Current Molecular Medicine 2004; 4 (3) . https://dx.doi.org/10.2174/1566524043360753
DOI https://dx.doi.org/10.2174/1566524043360753 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dedicated Breast CT: Current Status and New Directions
Current Medical Imaging The Pharmacological Treatment of Cachexia
Current Drug Targets Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Current Pharmaceutical Design The Prevention and Treatment of Delirium in Elderly Patients Following Hip Fracture Surgery
Recent Patents on CNS Drug Discovery (Discontinued) Improving Nutritional Quality of Plant Proteins Through Genetic Engineering
Current Genomics α-Amylase Inhibition: Some Practical Considerations
Current Enzyme Inhibition Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target
Current Medicinal Chemistry Aripiprazole in Children and Adolescents with Schizophrenia
Current Psychopharmacology T Allele of the <i>DRD2 Taq1</i>A Gene Polymorphism Increases the Predisposition to Drug Addiction in Indonesian Population
Current Pharmacogenomics and Personalized Medicine Ignored Avenues in Alpha-Synuclein Associated Proteopathy
CNS & Neurological Disorders - Drug Targets Blood Brain Barrier and Alzheimer’s Disease: Similarity and Dissimilarity of Molecular Alerts
Current Neuropharmacology Cardiovascular Effects of Green Tea Catechins: Progress and Promise
Recent Patents on Cardiovascular Drug Discovery Development of Xanthine Based Inhibitors Targeting Phosphodiesterase 9A
Letters in Drug Design & Discovery Editorial (Thematic Issue: W(e)nt to the Brain: Wnt Signaling in Neurological Disorders)
CNS & Neurological Disorders - Drug Targets From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Allergen-Induced Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Prevention and Treatment of Allergic Asthma in Pregnancy: From Conventional Drugs to New Therapeutical Approaches
Current Pharmaceutical Biotechnology Finding Recurrent Copy Number Alteration Regions: A Review of Methods
Current Bioinformatics Alcohol Abuse and Pancreatic Diseases: An Overview
Recent Patents on Inflammation & Allergy Drug Discovery Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex
Current Drug Metabolism